» Articles » PMID: 19017805

Inducible and Reversible Gene Silencing by Stable Integration of an ShRNA-encoding Lentivirus in Transgenic Rats

Overview
Specialty Science
Date 2008 Nov 20
PMID 19017805
Citations 85
Authors
Affiliations
Soon will be listed here.
Abstract

Currently, tools to generate loss-of-function mutations in rats are limited. Therefore, we have developed a lentiviral single-vector system for the temporal control of ubiquitous shRNA expression. Here, we report transgenic rats carrying an insulin receptor-specific shRNA transcribed from a regulatable promoter and identified by concomitant EGFP expression. In the absence of the inducer doxycycline (Dox), we observed no siRNA expression. However, Dox treatment at very low concentrations led to a rapid induction of the siRNA and ablation of INSR protein expression. As anticipated, blood glucose levels increased, whereas insulin signaling and glucose regulation were impaired. Importantly, this phenotype was reversible (i.e., discontinuation of Dox treatment led to INSR re-expression and remission of diabetes symptoms). The lentiviral system offers a simple tool for reversible gene ablation in the rat and can be used for other species that cannot be manipulated by conventional recombination techniques.

Citing Articles

Advancing the genetic engineering toolbox by combining AsCas12a knock-in mice with ultra-compact screening.

Jin W, Deng Y, La Marca J, Lelliott E, Diepstraten S, Konig C Nat Commun. 2025; 16(1):974.

PMID: 39885149 PMC: 11782673. DOI: 10.1038/s41467-025-56282-2.


Macropinocytosis mediates resistance to loss of glutamine transport in triple-negative breast cancer.

Wahi K, Freidman N, Wang Q, Devadason M, Quek L, Pang A EMBO J. 2024; 43(23):5857-5882.

PMID: 39420093 PMC: 11611898. DOI: 10.1038/s44318-024-00271-6.


Combined Inhibition of EZH2 and FGFR is Synergistic in BAP1-deficient Malignant Mesothelioma.

Badhai J, Landman N, Pandey G, Song J, Hulsman D, Krijgsman O Cancer Res Commun. 2023; 4(1):18-27.

PMID: 38054839 PMC: 10763530. DOI: 10.1158/2767-9764.CRC-23-0276.


Deletion of the transcriptional regulator TFAP4 accelerates c-MYC-driven lymphomagenesis.

Potts M, Mizutani S, Garnham A, Li Wai Suen C, Kueh A, Tai L Cell Death Differ. 2023; 30(6):1447-1456.

PMID: 36894688 PMC: 10244435. DOI: 10.1038/s41418-023-01145-w.


Immunity against Moraxella catarrhalis requires guanylate-binding proteins and caspase-11-NLRP3 inflammasomes.

Enosi Tuipulotu D, Feng S, Pandey A, Zhao A, Ngo C, Mathur A EMBO J. 2023; 42(6):e112558.

PMID: 36762431 PMC: 10015372. DOI: 10.15252/embj.2022112558.


References
1.
Benson J, Chen Y, Cornell-Kennon S, Dorsch M, Kim S, Leszczyniecka M . Validating cancer drug targets. Nature. 2006; 441(7092):451-6. DOI: 10.1038/nature04873. View

2.
Saltiel A, Kahn C . Insulin signalling and the regulation of glucose and lipid metabolism. Nature. 2001; 414(6865):799-806. DOI: 10.1038/414799a. View

3.
Glaser S, Anastassiadis K, Stewart A . Current issues in mouse genome engineering. Nat Genet. 2005; 37(11):1187-93. DOI: 10.1038/ng1668. View

4.
Tuschl T . Expanding small RNA interference. Nat Biotechnol. 2002; 20(5):446-8. DOI: 10.1038/nbt0502-446. View

5.
Pfeifer A . Lentiviral transgenesis--a versatile tool for basic research and gene therapy. Curr Gene Ther. 2006; 6(4):535-42. DOI: 10.2174/156652306777934856. View